New Mexico Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Health Reporter.

Press releases published on November 12, 2026

11 hours ago

LEQEMBI® Pen (Subcutaneous Formulation of LEQEMBI®) Now Available in Japan for Patients with Early Alzheimer’s Disease

Indeterminate GlobeNewswire

11 hours ago

Windward Bio Announces Pricing of Initial Public Offering

Indeterminate GlobeNewswire

12 hours ago

VitalHub Reports Third Quarter 2026 Results

Indeterminate GlobeNewswire

13 hours ago

POTS Phase 2 Trial Shows Baloncibart, a First-in-Class NPR1 Blocking Antibody, Reduced Orthostatic Heart Rate and Improved Orthostatic Symptoms

Indeterminate GlobeNewswire

13 hours ago

Longeveron Announces 2026 Third Quarter Financial Results and Provides Business Update

Indeterminate GlobeNewswire

13 hours ago

Eledon Pharmaceuticals Reports Third Quarter 2026 Financial Results and Recent Business Highlights

Indeterminate GlobeNewswire

13 hours ago

YD Bio Announces FDA Grant of INTERACT Meeting Request for YDB-LMSCEV-001, an Investigational Extracellular Vesicle Candidate for Dry Eye Disease

Indeterminate GlobeNewswire

13 hours ago

Sutro Biopharma Reports Third Quarter 2026 Financial Results and Business Highlights

Indeterminate GlobeNewswire

13 hours ago

New Drug Application Submission Completed for Zipalertinib Plus Chemotherapy in First-Line EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer

Indeterminate GlobeNewswire

13 hours ago

Praxis Precision Medicines Details Launch Readiness for Relutrigine and Ulixacaltamide and Outlines Expanded Pipeline in Preparation to be the Preeminent CNS Biotech at Investor Day

Indeterminate GlobeNewswire

13 hours ago

Serina Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Updates 

Indeterminate GlobeNewswire

13 hours ago

BioCardia Reports Third Quarter 2026 Business Highlights and Financial Results

Indeterminate GlobeNewswire

13 hours ago

Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del tercer trimestre de 2026

Indeterminate GlobeNewswire

13 hours ago

Verrica Pharmaceuticals Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

13 hours ago

Prime Medicine Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Indeterminate GlobeNewswire

13 hours ago

InspireMD Announces Proposed Public Offering

Indeterminate GlobeNewswire

13 hours ago

BIO GREEN MED SOLUTION REPORTS THIRD QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Indeterminate GlobeNewswire

13 hours ago

Voting Rights and Shares Capital of the Company

Indeterminate GlobeNewswire

13 hours ago

Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social

Indeterminate GlobeNewswire

13 hours ago

Immix Biopharma Reports Third Quarter 2026 Financial Results and Update on Corporate Progress

Indeterminate GlobeNewswire